Screener
Tyra Biosciences, Inc. TYRA Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.
The source filing: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 8:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220645
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total operating expenses | 41,998 | 31,850 |
| Loss from operations | (41,998) | (31,850) |
| Other income: | ||
| Interest and other income, net | 2,693 | 3,703 |
| Total other income | 2,693 | 3,703 |
| Net loss | (39,305) | (28,147) |
| Unrealized loss on marketable securities, net | (286) | (82) |
| Comprehensive loss | $(39,591) | $(28,229) |
Item 1. Condensed Financial Statements
FAQ
- What is Tyra Biosciences, Inc.'s interest income?
- Tyra Biosciences, Inc. (TYRA) reported interest income of $2.69M in Q1 2026.
- How has Tyra Biosciences, Inc.'s interest income changed year-over-year?
- Tyra Biosciences, Inc.'s interest income decreased by 27.3% year-over-year, from $3.7M to $2.69M.
- What is the long-term trend for Tyra Biosciences, Inc.'s interest income?
- Over 2 years (2023 to 2025), Tyra Biosciences, Inc.'s interest income has grown at a 8.9% compound annual growth rate (CAGR), from $10.81M to $12.82M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Tyra Biosciences, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude